Related references
Note: Only part of the references are listed.Microbiological, Epidemiological, and Clinical Characteristics of Patients With Cryptococcal Meningitis at a Tertiary Hospital in China: A 6-Year Retrospective Analysis
Yanbing Li et al.
FRONTIERS IN MICROBIOLOGY (2020)
Cerebrovascular injury in cryptococcal meningitis
Ajay Kumar Mishra et al.
INTERNATIONAL JOURNAL OF STROKE (2018)
Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy
Peter R. Williamson et al.
NATURE REVIEWS NEUROLOGY (2017)
Subarachnoid small vein occlusion due to inflammatory fibrosis-a possible mechanism for cerebellar infarction in cryptococcal meningoencephalitis: a case report
Yoshiteru Shimoda et al.
BMC NEUROLOGY (2017)
Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis
Tihana Bicanic et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Comparisons of presentations and outcomes of cryptococcal meningitis between patients with and without hepatitis B virus infection
Yu-Hua Zhong et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2014)
Infectious causes of stroke
Jennifer E. Fugate et al.
LANCET INFECTIOUS DISEASES (2014)
Epidemiology of Cryptococcal Meningitis in the US: 1997-2009
Vasilios Pyrgos et al.
PLOS ONE (2013)
Comparison of 2 Doses of Liposomal Amphotericin B and Conventional Amphotericin B Deoxycholate for Treatment of AIDS-Associated Acute Cryptococcal Meningitis: A Randomized, Double-Blind Clinical Trial of Efficacy and Safety
Richard J. Hamill et al.
CLINICAL INFECTIOUS DISEASES (2010)
Cryptococcal thyroiditis and hyperthyroidism
AM Avram et al.
THYROID (2004)
Share Paper
